Integre Asset Management’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
Sell
-36,231
Closed -$330K 155
2014
Q3
$330K Sell
36,231
-140
-0.4% -$1.33K 0.07% 144
2014
Q2
$359K Sell
36,371
-975
-3% -$8.27K 0.08% 143
2014
Q1
$474K Sell
37,346
-36,232
-49% -$538K 0.1% 134
2013
Q4
$1.1M Buy
73,578
+8,301
+13% +$107K 0.25% 65
2013
Q3
$721K Buy
+65,277
New +$544K 0.19% 83

Other funds holding HALO

Integre Asset Management's HALO Position: Q4 2014 in Review

Integre Asset Management sold out of Halozyme (HALO) in Q4 2014, closing a stake of 36,231 shares — an estimated $330K sold.

Integre Asset Management first reported a position in HALO in Q3 2013 and held it in 5 quarters. The position peaked at $1.1M in Q4 2013. 132 funds tracked by Wall St. Rank hold HALO as of Q4 2014.

  • Integre Asset Management reported no remaining Halozyme position as of Q4 2014 after selling out during the quarter.
  • Integre Asset Management sold 36,231 Halozyme shares in Q4 2014, an estimated $330K.
  • Integre Asset Management first reported a position in Halozyme in Q3 2013 and held it in 5 quarters.
  • Integre Asset Management's Halozyme position peaked at $1.1M in Q4 2013.
  • 132 funds tracked by Wall St. Rank held Halozyme as of Q4 2014.

Based on Integre Asset Management's 13F filing for Q4 2014, filed 17 Feb 2015.